Sunny Kang

Sunny Kang

Auto-generated profile, based on publicly available information

Sunny Kang

Department of Internal Medicine, College of Korean Medicine, Wonkwang University, Iksan, Republic of Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2021 in Journal of Korean Medical Society of Soft Tissue
Verified
Journal Article
Open access
PDF file
Cheol-Hyun KimCheol-Hyun Kim
Cheol-Hyun Kim
KKKwangho Kim
Kwangho Kim
YLYoung-Ung Lee
Young-Ung Lee
SKSunny Kang
Sunny Kang

30 June 2026 in Perspectives on Integrative Medicine
Verified
Journal Article
Open access
YSYoungjo So
Youngjo So
JKJiwoo Kim
Jiwoo Kim
HCHyeongyu Cho
Hyeongyu Cho
SJSangho Ji
Sangho Ji
SKSunny Kang
Sunny Kang
Cheol-Hyun KimCheol-Hyun Kim
Cheol-Hyun Kim
Background: Central post-stroke pain (CPSP) is a representative central neuropathic pain syndrome caused by lesions of the thalamus or spinothalamic tract. Current diagnostic approaches rely on subjective symptom reporting. Quantitative electroencephalography (qEEG) has gained attention as a noninvasive neurophysiological biomarker with the potential to overcome these limitations.Methods: A total of 50 stroke patients will be recruited at a single center and allocated into either a CPSP group (n = 25) or a control group without central neuropathic pain (n = 25). Using a 2-channel frontal EEG device (Fp1-Fp2), resting-state EEG will be recorded for 5 minutes under both eyes-open and eyes-closed conditions, followed by a 2-minute EEG acquisition during cold stimulation. After artifact removal, frontal asymmetry indices, the delta-to-alpha ratio, and the delta-theta to beta-alpha ratio will be computed. These qEEG parameters will be compared between groups alongside clinical variables including the Neuropathic Pain Symptom Inventory, Patient Health Questionnaire-9, and relevant medical history.Conclusion: This study seeks to identify distinctive qEEG features such as increased slow-wave activity and altered frontal asymmetry in patients with CPSP, thereby providing foundational evidence for establishing qEEG as an objective tool for early diagnosis and standardized assessment of CPSP. Although the single-center design and the limited spatial resolution of the 2-channel EEG system represent inherent constraints, this study protocol is expected to serve as an essential basis for future multi-channel qEEG investigations, machine learningbased analyses, and individualized intervention assessments in CPSP research.

1 January 2025 in Parkinson's Disease
Verified
Journal Article
Open access
Cheol-Hyun KimCheol-Hyun Kim
Cheol-Hyun Kim
Taeseok AhnTaeseok Ahn
Taeseok Ahn
YSYoungjo So
Youngjo So
HCHyeongyu Cho
Hyeongyu Cho
JKJiwoo Kim
Jiwoo Kim
NKNamKwen Kim
NamKwen Kim
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder with significant social costs, mainly owing to hospitalization, which is frequently associated with high levodopa equivalent daily dose (LEDD) and polypharmacy rather than neurological symptoms alone. Integrative treatment combining Western and Korean medicine may help control these factors and reduce the need for hospitalization. We investigated the potential impact of integrative treatment on LEDD and polypharmacy in patients with PD > 5 years postdiagnosis. Methods: Fifteen patients with PD (KCD code G20), diagnosed > 5 years earlier, who received integrative treatment at Gwangju Korean Medicine Hospital, Wonkwang University, from April 1, 2022, to July 30, 2024, were enrolled. A retrospective chart review was conducted to collect demographic and clinical data, including LEDD, medication count, and treatment details. Summary statistics were presented as median (IQR) and mean ± SD. Results: In the integrative treatment cohort, the prevalence of both LEDD and polypharmacy was lower than that in studies involving conventional treatment alone. The mean LEDD was 321.71 (median, 200.0) mg, while only two patients exceeded the LEDD threshold of 300 mg, which was associated with motor complications. Polypharmacy was observed in 13.3% of patients and hyperpolypharmacy in 6.7%, representing lower proportions compared with previous reports on conventional treatments. Representative cases highlighted symptom improvement and a reduced need for medication with integrative approaches, particularly acupuncture and herbal medicine. Conclusion: These findings suggest that integrative treatment may contribute to lowering LEDD and medication counts in patients with PD, which could potentially reduce hospitalization rates and the associated social costs. Further prospective studies comparing the integrative and nonintegrative treatment groups are needed to clarify these findings and evaluate the role of integrative treatment in the long‐term management of PD.

30 June 2022 in Journal of Korean Medical Society of Acupotomology
Verified
Journal Article
Open access
PDF file
KKKwangho Kim
Kwangho Kim
YLYoung-Ung Lee
Young-Ung Lee
SKSunny Kang
Sunny Kang
Cheol-Hyun KimCheol-Hyun Kim
Cheol-Hyun Kim
SLSangkwan Lee
Sangkwan Lee
Kwangho Kim, Young-ung Lee, Sunny Kang, Cheol-hyun Kim, Sangkwan Lee. Journal of Korean Medical Society of Soft Tissue 2022;6:44-50. https://doi.org/10.54461/JKMST.2022.6.1.44